---

Development of the Urinary System and Prostate Gland

---

PART 1: DEVELOPMENT OF THE URINARY SYSTEM

Overview and Origin

• Kidneys (produce and excrete urine)
• Ureters (convey urine to the bladder)
• Urinary bladder (stores urine)
• Urethra (discharges urine)

---

DEVELOPMENT OF KIDNEYS AND URETERS

---

1. Pronephroi (Week 4)

• Appear early in the 4th week as a few bilateral cell clusters and tubular structures in the cervical (neck) region
• The pronephric ducts run caudally and open into the cloaca (a common chamber receiving hindgut and allantois)
• These rudimentary structures are non-functional in humans
• The pronephroi soon degenerate, but most of their ducts persist and are adopted by the next kidney system

---

2. Mesonephroi (Late Week 4 - Week 12)

• Large, elongated excretory organs appearing late in week 4, caudal to pronephroi
• Function as interim kidneys for ~4 weeks until permanent kidneys develop
• Consist of 10-50 glomeruli per kidney and mesonephric tubules
• Tubules drain into mesonephric (Wolffian) ducts, which open into the cloaca
• Degenerate by end of week 12
• Important remnants in males:
  • Mesonephric tubules become efferent ductules of the testes
  • Mesonephric ducts form the epididymis, vas deferens, seminal vesicles, and ejaculatory ducts

---

3. Metanephroi - The Permanent Kidneys (Week 5 onward)

A. Ureteric Bud (Metanephric Diverticulum)

• Outgrowth from the mesonephric duct near its entry into the cloaca (week 5)
• Penetrates the metanephric blastema (metanephrogenic mesenchyme)
• Gives rise to: ureter, renal pelvis, calyces, collecting tubules

B. Metanephric Blastema (Metanephrogenic Mesenchyme)

• Derived from the caudal portion of the nephrogenic cord (intermediate mesoderm)
• Induced by the ureteric bud to form: nephrons (glomeruli, proximal tubules, loops of Henle, distal tubules)

Reciprocal Induction

• The ureteric bud induces the mesenchyme to differentiate into nephrons
• The mesenchyme induces the bud to branch and grow
• This reciprocal process continues until 32-36 weeks of gestation

---

Ascent of the Kidneys (Weeks 6-9)

• Initially, the metanephric kidneys lie in the pelvis
• They ascend to their lumbar position by weeks 6-9 due to:
  • Body growth (caudal end elongates)
  • Reduction in body curvature
• During ascent, the kidneys receive successive blood supplies from increasingly cranial aortic branches
• The hilum, initially facing ventrally, rotates 90 degrees medially
• The kidneys reach the suprarenal glands by week 9, fixing their final position

Changes in Blood Supply During Ascent

• Initially: renal arteries branch from common iliac arteries
• Then: blood supply from distal aorta
• Finally: permanent renal arteries from abdominal aorta (the most cranial branches)
• Caudal branches involute and disappear

---

Development of Urinary Bladder

• Derived from the upper part of the urogenital sinus (which forms when the urorectal septum divides the cloaca)
• The allantois (connecting to the umbilicus) becomes the urachus at its upper end - later obliterating into the median umbilical ligament
• As the bladder enlarges, distal mesonephric ducts are incorporated into its dorsal wall, contributing to the trigone
• The ureters open separately into the bladder and their orifices migrate superolaterally due to kidney ascent
• In males: mesonephric duct orifices move together to enter the prostatic urethra as ejaculatory ducts
• In infants and children, the bladder is in the abdomen even when empty; it enters the greater pelvis at ~6 years, and enters the true pelvis only after puberty

---

Development of Urethra

• Develops from the lower part of the urogenital sinus
• The entire epithelium of the male urethra (including the prostatic, membranous, and spongy parts) is of urogenital sinus origin
• The glandular urethra (glans penis) develops by canalization of an ectodermal ingrowth

---

CONGENITAL ANOMALIES OF THE URINARY SYSTEM

Renal Agenesis

• Absent kidneys → no fetal urine production → oligohydramnios
• Results in: pulmonary hypoplasia, Potter facies (flattened nose, recessed chin, low-set ears, skin folds under eyes), limb deformities (talipes equinovarus)
• Incompatible with postnatal life due to pulmonary hypoplasia

---

Horseshoe Kidney

• Inferior poles fuse during ascent, usually across the inferior mesenteric artery (IMA) - which prevents further cranial migration
• The kidney lies lower than normal, with its hilum facing anteriorly
• Occurs in ~1 in 500 people; more common in males
• Most cases are asymptomatic; associated with increased risk of:
  • Ureteropelvic junction (UPJ) obstruction and hydronephrosis
  • Renal calculi
  • Wilms tumor (nephroblastoma)
  • Trisomy 18 (Edwards syndrome)

---

Pelvic Kidney (Ectopic Kidney)

• Kidney fails to ascend - remains in the pelvis
• May receive blood supply from iliac vessels or lower aorta
• Usually asymptomatic but predisposed to infection and hydronephrosis
• Occasionally discovered incidentally on imaging

---

Duplex Ureter / Double Collecting System

• Caused by early division of the ureteric bud before it contacts the metanephric blastema
• Results in two separate ureters (one or both sides)
• The ectopic ureter (from the upper moiety) inserts below the normal trigonal position, following the Weigert-Meyer rule:
  • Upper moiety ureter: inserts inferomedially (ectopically) → tends to obstruct
  • Lower moiety ureter: inserts superolaterally → tends to reflux

---

Accessory Renal Arteries

• Present in ~25% of adults (2-4 renal arteries)
• Arise from the aorta superior or inferior to the main renal artery
• An accessory artery crossing anterior to the ureter at the inferior pole can cause UPJ obstruction and hydronephrosis
• Accessory arteries are end arteries - ligation causes ischemic infarction of supplied tissue
• Approximately twice as common as accessory veins

---

Polycystic Kidney Disease

---

Urachal Anomalies

---

Vesicoureteral Reflux (VUR)

• The most common urinary tract anomaly in children
• Due to failure of the intramural ureter to develop an adequate submucosal tunnel
• Allows urine to reflux from bladder into ureters/kidneys during voiding
• Graded I-V (I = ureter only; V = massive dilation with intrarenal reflux)
• Predisposes to recurrent UTI and reflux nephropathy (scarring)
• May resolve spontaneously (lower grades); higher grades may need surgical correction

---

Bladder Exstrophy

• Failure of mesodermal migration to reinforce the anterior abdominal wall over the developing bladder
• Results in the posterior bladder wall being exposed on the abdominal surface
• Associated with epispadias in males
• Increased risk of bladder adenocarcinoma if untreated
• Requires surgical reconstruction

---

Renal Tubular Defects

• Congenital hydronephrosis - most commonly due to UPJ obstruction; detected prenatally on ultrasound
• Multicystic dysplastic kidney (MCDK) - non-hereditary; caused by atresia of the ureter early in development; kidney replaced by non-communicating cysts; usually unilateral; involutes over time

---

PART 2: DEVELOPMENT OF THE PROSTATE GLAND

Origin and Embryological Context

• The urorectal septum divides the cloaca into a dorsal anorectal canal and ventral primitive urogenital sinus
• The urogenital sinus further differentiates into:
  • Bladder (cranial portion)
  • Pelvic urethra (middle portion - prostatic and membranous in males)
  • Phallic urethra (caudal portion)
• The prostate develops from the pelvic portion of the urogenital sinus epithelium (UGE), specifically from FOXA1-positive endodermal cells

---

Androgenic Control of Prostate Development

• Fetal testes produce testosterone from Leydig cells under the stimulation of human chorionic gonadotropin (hCG), which peaks at weeks 8-12
• Within the urogenital sinus (UGS), testosterone is converted to dihydrotestosterone (DHT) by 5α-reductase
• DHT binds to androgen receptors (AR) in the urogenital sinus mesenchyme (UGM) - not the epithelium
• AR signaling in UGM is required for prostate induction via paracrine signaling to adjacent UGE (the "andromechanist" hypothesis)
• This was proven by recombination experiments: AR-null mesenchyme cannot induce prostate budding even in wild-type epithelium

---

Stages of Prostate Development

---

Anatomical Development

• Peripheral zone (70% of adult prostate, site of most cancers) - from lateral UGE buds
• Central zone (25%) - from periurethral UGE
• Transition zone (5%, site of BPH) - from periurethral region

---

Molecular Regulation of Prostate Development

---

Development of Seminal Vesicles

• Appear as a diverticulum of the Wolffian (mesonephric) duct at about weeks 10-12 of gestation
• The diverticulum elongates and folds back on itself to form a "hook-like duct" with extensive side ducts developing during months 4-5
• Autonomic innervation develops by week 13
• Malformations are extremely rare; seminal vesicle cysts can occur

---

CLINICAL CORRELATIONS OF PROSTATE DEVELOPMENT

1. Benign Prostatic Hyperplasia (BPH)

• Developmental significance: BPH represents a reactivation of prostatic developmental pathways - specifically re-awakening of the embryonic inductive interaction between stroma and epithelium (epithelial-mesenchymal interaction)
• Develops in the transition zone (same periurethral zone where prostatic buds first emerge)
• Androgen-dependent (testosterone/DHT) but also involves estrogen signaling
• Stroma-to-epithelium paracrine signaling mirrors fetal development

• Lower urinary tract symptoms (LUTS): weak stream, hesitancy, frequency, nocturia, incomplete emptying
• Complications: acute urinary retention, hydronephrosis, bladder stones, recurrent UTI
• Treatment: alpha blockers (tamsulosin), 5α-reductase inhibitors (finasteride - blocks conversion of T to DHT), TURP

---

2. Prostate Cancer

• Most cancers arise in the peripheral zone
• PSA (prostate-specific antigen) is expressed throughout prostatic development and serves as a biomarker
• NKX3.1 - expressed early in prostate development as a lineage marker, later acts as a tumor suppressor; its loss is one of the earliest events in prostate carcinogenesis
• Reactivation of developmental programs (AR signaling, epithelial-mesenchymal transition) drives cancer progression

---

3. 5α-Reductase Deficiency

• Type 2 5α-reductase is expressed in the UGS during development
• Deficiency results in: normal Wolffian duct derivatives (testosterone-dependent), but markedly underdeveloped prostate, external genitalia feminization (pseudovaginal perineoscrotal hypospadias), and bifid scrotum
• Testes are present but undescended; AMH is normal so Müllerian structures are absent
• At puberty, rising testosterone drives virilization (voice deepening, muscle mass, phallus enlargement) - the classic "guevedoces" presentation
• Confirms the principle that DHT, not testosterone, is required for prostate and external genitalia formation

---

4. Androgen Insensitivity Syndrome (AIS)

• X-linked; AR gene mutations
• Complete AIS (CAIS): 46,XY; no functional AR; female external phenotype; absent uterus (AMH is normal); no prostate development; testes in inguinal canal or labia
• Partial AIS: variable phenotype depending on degree of AR dysfunction; rudimentary prostate may form
• AMH-mediated Müllerian regression is normal (not AR-dependent)

---

5. Hypospadias

• Failure of normal urethral plate canalization and/or urethral fold fusion
• In ~10% of severe cases, associated with DSD (differences of sex development)
• The prostatic urethra and prostate remain relatively unaffected; the penile/glandular urethra is the primary abnormality
• Associated with reduced androgen exposure or AR signaling defects in mild forms

---

6. Prostatitis Syndromes

• Embryological background relevant to understanding anatomy: the zonal structure of the prostate and its ductal drainage patterns determine which zones are most susceptible to inflammatory conditions
• Acute bacterial prostatitis - often involves the peripheral zone
• Chronic prostatitis/CPPS - may relate to abnormal ductal architecture from developmental variants

---

SUMMARY TABLE: Developmental Origins of Urogenital Structures

---

• The Developing Human: Clinically Oriented Embryology (Moore et al.) - Chapter 12
• Campbell-Walsh-Wein Urology - Chapters 20 and 143 (Development of the Prostate)